J&J Trading Near 52-Week Low: Should You Sell the Stock?

J&J’s (JNJ) stock closed at $145.05 on Friday, quite close to its 52-week low of $142.75. In the past three months, J&J’s stock has lost more than 10%.Slowing sales of J&J’s MedTech segment, the upcoming patent expiration of its blockbuster drug, Stelara and talc-related legal issues are some of J&J’s main concerns. The overall drug and biotech sector saw a major downturn in the second half of the year due to disappointing third-quarter sales and profits, guidance cuts, pipeline setbacks and the appointment ...